|
334 genotypes with 336 annotations displayed
of selected term and subterms
|
|
Searched Term: abnormal metastatic potential
|
Adipoqtm1Chan/Adipoq+
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Adipoqtm1Chan Tg(MMTV-PyVT)634Mul)
|
increased metastatic potential
|
J:147458
|
Adipoqtm1Chan/Adipoq+
Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-Adipoqtm1Chan Tg(MMTV-PyVT)634Mul)
|
increased metastatic potential
|
J:147458
|
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ)
|
increased metastatic potential
|
J:149060,
J:142150
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: 129 * C57BL/6)
|
decreased metastatic potential
|
J:153690
|
Anxa1tm1Rjf/Anxa1tm1Rjf
Tg(MMTV-PyVT)634Mul/?
(involves: FVB/N)
|
decreased metastatic potential
|
J:174635
|
ApcMin/Apc+
Hltftm1.1Hdin/Hltftm1.1Hdin
(involves: 129 * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:252991
|
Apctm1Rak/Apc+
Dcctm1.1Mehl/Dcctm1.1Mehl
(involves: 129P2/OlaHsd * C57BL/6)
|
increased metastatic potential
|
J:181517
|
Apctm2Rak/Apc+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
increased metastatic potential
|
J:234310
|
Apctm2Rfo/Apc+
((C57BL/6J x 129P2/OlaHsd)F1)
|
increased metastatic potential
|
J:204440
|
Arid1atm1.1Mag/Arid1atm1.1Mag
Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * CD-1)
|
increased metastatic potential
|
J:219794
|
Atf2Tg(Gzma-Klra1)7Wum/Atf2+
(involves: C57BL/6)
|
increased metastatic potential
|
J:61178
|
Atf3tm1.1Hai/Atf3tm1.1Hai
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * FVB/N)
|
decreased metastatic potential
|
J:201626
|
Atf3tm1Dron/Atf3tm1Dron
(involves: 129X1/SvJ * C57BL/6)
|
decreased metastatic potential
|
J:201626
|
Atf3tm1Dron/Atf3tm1Dron
Tg(MMTV-PyVT)634Mul/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:201626
|
Atp6v0a2tm1Kdb/Atp6v0a2tm1Kdb
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
increased metastatic potential
|
J:274048
|
Bcl11btm1Peli/Bcl11btm1Peli
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J)
|
decreased metastatic potential
|
J:161373
|
Bhlha15tm2(Kras)Skz/Bhlha15+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
increased metastatic potential
|
J:105076
|
Braftm1.1Brd/Braf+
Tg(Vil1-cre)997Gum/0
Trp53tm2Tyj/Trp53tm2Tyj
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased metastatic potential
|
J:199307
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
increased metastatic potential
|
J:170095
|
Braftm1Mmcm/Braf+
Ptentm1Rdp/Ptentm1Rdp
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:151023
|
Braftm1Mmcm/Braf+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(Tyr-cre/ERT2)13Bos/0
(involves: 129P2/OlaHsd * 129S1/Sv * FVB)
|
increased metastatic potential
|
J:151023
|
Braftm1Mmcm/Braf+
Tg(TPO-cre/ERT2)1139Tyj/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6NTac)
|
increased metastatic potential
|
J:208854
|
Braftm1Mmcm/Braftm1Mmcm
Nkx3-1tm4(cre/ERT2)Mms/Nkx3-1+
Ptentm1Hwu/Pten+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
increased metastatic potential
|
J:191327
|
Brca1tm1Bhk/Brca1+
Cdkn2ctm1Yxi/Cdkn2ctm1Yxi
(C.129-Cdkn2ctm1Yxi Brca1tm1Bhk)
|
increased metastatic potential
|
J:198018
|
Brca1tm1Brn/Brca1tm1Brn
Tg(Krt18-EGFP,-TAg121)36Ysng/0
Trp53tm1Brn/Trp53tm2Tyj
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
|
increased metastatic potential
|
J:189304
|
Brca1tm2Cxd/Brca1tm2Cxd
Pkmtm1.1Mgvh/Pkmtm1.1Mgvh
Trp53tm1Brd/Trp53+
Tg(MMTV-cre)4Mam/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)
|
increased metastatic potential
|
J:205213
|
Calcatm1.1(cre/ERT2)Ptch/Calca+
Trp53tm1Brn/Trp53tm1Brn
Rb1tm2Brn/Rb1tm2Brn
Ptentm1Hwu/Ptentm1Hwu
(involves: 129 * 129P2/OlaHsd * 129S4/SvJae * BALB/c * FVB/N)
|
increased metastatic potential
|
J:190366
|
Casp1tm1Flv/Casp1tm1Flv
Casp4del/Casp4del
(involves: 129S2/SvPas)
|
decreased metastatic potential
|
J:59893
|
Ccdc25em1Smoc/Ccdc25em1Smoc
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6NTac * FVB/N)
|
decreased metastatic potential
|
J:291299
|
Ccdc80tm1Ppal/Ccdc80tm1Ppal
(Not Specified)
|
increased metastatic potential
|
J:217742
|
Ccm2ltm1Mlkn/Ccm2ltm1Mlkn
(involves: 129 * C57BL/6)
|
decreased metastatic potential
|
J:187714
|
Ccn6tm1.1Cgkl/Ccn6tm1.1Cgkl
Tg(MMTV-cre)1Mam/0
(FVB/N-Ccn6tm1.1Cgkl Tg(MMTV-cre)1Mam)
|
increased metastatic potential
|
J:241259
|
Ccn6tm1.1Cgkl/Ccn6tm1.1Cgkl
Tg(MMTV-cre)1Mam/0
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Ccn6tm1.1Cgkl Tg(MMTV-cre)1Mam Tg(MMTV-PyVT)634Mul)
|
increased metastatic potential
|
J:241259
|
Ccr5tm1Kuz/Ccr5tm1Kuz
Tg(CAG-EGFP)1Osb/?
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
decreased metastatic potential
|
J:97833
|
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
decreased metastatic potential
|
J:118828
|
Cd44tm1Mak/Cd44tm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:100774
|
Cd44tm1Mak/Cd44tm1Mak
Tg(MMTV-PyVT)634Mul/0
(B6.Cg-Cd44tm1Mak Tg(MMTV-PyVT)634Mul)
|
increased metastatic potential
|
J:100774
|
Cd44tm1Mak/Cd44tm1Mak
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * C57BL/6J)
|
decreased metastatic potential
|
J:76201
|
Cd96tm1.1Mjs/Cd96tm1.1Mjs
(B6.129P2(Cg)-Cd96tm1.1Mjs)
|
decreased metastatic potential
|
J:209990
|
Cd226tm1.1Cln/Cd226tm1.1Cln
(B6.129P2-Cd226tm1.1Cln)
|
increased metastatic potential
|
J:159749
|
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53+
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased metastatic potential
|
J:116152
|
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53+
Tg(Wap-cre)51Nki/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased metastatic potential
|
J:171765
|
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased metastatic potential
|
J:116152
|
Cdh1tm1Jjon/Cdh1tm1Jjon
Trp53tm1Brn/Trp53tm1Brn
Tg(Wap-cre)51Nki/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased metastatic potential
|
J:171765
|
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
(involves: 129 * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:212549
|
Cdh1tm2Kem/Cdh1+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)6Tuv/0
(involves: 129 * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:212549
|
Cdh13tm1Brns/Cdh13tm1Brns
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:132759
|
Cdk4+/Cdk4+
Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb)
|
increased metastatic potential
|
J:111992
|
Cdk4tm1.1Bbd/Cdk4+
Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb)
|
increased metastatic potential
|
J:111992
|
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd
Krt14tm1(cre)Wbm/Krt14+
Pard3tm1Shoh/Pard3tm1Shoh
Tg(Mt1-Hgf)#Lmb/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
increased metastatic potential
|
J:240961
|
Cdk4tm1.1Bbd/Cdk4tm1.1Bbd
Tg(Mt1-Hgf)#Lmb/0
(B6.Cg-Cdk4tm1.1Bbd Tg(Mt1-Hgf)#Lmb)
|
increased metastatic potential
|
J:111992
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S1/SvImJ * 129S2/SvPas * C57BL/6J)
|
increased metastatic potential
|
J:83967
|
Cdkn2atm1.1Brn/Cdkn2a+
Nf2tm2Gth/Nf2tm2Gth
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
increased metastatic potential
|
J:132943
|
Cdkn2atm1Cjs/Cdkn2atm1Cjs
(involves: 129X1/SvJ * C57BL/6 * NIH/OlaHsd)
|
increased metastatic potential
|
J:93298
|
Cdkn2atm1Rdp/Cdkn2a+
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0
Tg(Pdx1-cre)6Tuv/0
Tg(tetO-MYC)36Bop/0
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
increased metastatic potential
|
J:197052
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Tg(Tyr-NRAS*Q61K)1Bee/?
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL)
|
increased metastatic potential
|
J:98545
|
Cdkn2atm2.1Brn/Cdkn2atm2.1Brn
(involves: 129P2/OlaHsd * FVB/N)
|
increased metastatic potential
|
J:71393
|
Cdkn2atm2.1Nesh/Cdkn2atm2.1Nesh
Nrastm1.1Nesh/Nrastm1.1Nesh
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Tyr-cre/ERT2)13Bos/0
(B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nrastm1.1Nesh Cdkn2atm2.1Nesh Stk11tm1.1Rdp)
|
increased metastatic potential
|
J:220627
|
Cdkn2atm2.1Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:108298
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:124682
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:108298
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:108298
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:108298
|
Cdkn2atm4Rdp/Cdkn2a+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:108298
|
Cdkn2atm4Rdp/Cdkn2atm4Rdp
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:108298,
J:87196
|
Cks1btm1Sir/Cks1btm1Sir
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL)
|
decreased metastatic potential
|
J:121564
|
Col1a1tm1(tetO-URI1)Ndj/Col1a1+
Tg(Cebpb-tTA)#Bjd/0
(B6.Cg-Col1a1tm1(tetO-URI1)Ndj Tg(Cebpb-tTA)#Bjd)
|
increased metastatic potential
|
J:217463
|
Cpt1cGt(XL823)Byg/Cpt1c+
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased metastatic potential
|
J:228258
|
Cst3tm1Karl/Cst3tm1Karl
(involves: 129S/SvEv * C57BL/6)
|
increased metastatic potential
|
J:62407
|
Ctsbtm1Jde/Ctsbtm1Jde
Ctsztm1Thre/Ctsztm1Thre
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsztm1Thre Ctsbtm1Jde Tg(MMTV-PyVT)634Mul)
|
decreased metastatic potential
|
J:157541
|
Ctsbtm1Jde/Ctsbtm1Jde
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsbtm1Jde Tg(MMTV-PyVT)634Mul)
|
decreased metastatic potential
|
J:157541
|
Ctsztm1Thre/Ctsztm1Thre
Tg(MMTV-PyVT)634Mul/0
(FVB.129P2-Ctsztm1Thre Tg(MMTV-PyVT)634Mul)
|
decreased metastatic potential
|
J:157541
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(B6.Cg-Il8rbtm1Mwm)
|
decreased metastatic potential
|
J:88233
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din)
|
decreased metastatic potential
|
J:110181
|
Dcctm1Nki/Dcctm1Nki
Trp53tm1Brn/Trp53tm1Brn
Tg(KRT14-cre)8Brn/?
(involves: 129P2/OlaHsd * FVB/N)
|
increased metastatic potential
|
J:181090
|
Ddr2tm1a(EUCOMM)Wtsi/Ddr2tm1a(EUCOMM)Wtsi
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB/N)
|
decreased metastatic potential
|
J:236031
|
Ddr2tm1b(EUCOMM)Wtsi/Ddr2tm1b(EUCOMM)Wtsi
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6N * FVB/N)
|
decreased metastatic potential
|
J:236031
|
Ddr2tm1c(EUCOMM)Wtsi/Ddr2tm1c(EUCOMM)Wtsi
Tg(KRT14-cre)1Amc/0
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * C57BL/6N * CBA * FVB/N)
|
decreased metastatic potential
|
J:236031
|
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd)
|
increased metastatic potential
|
J:182161
|
Dicer1tm1Tara/Dicer1tm1Tara
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd)
|
increased metastatic potential
|
J:222579
|
Dmq3M16i/?
(involves: FVB/NJ * M16i)
|
increased metastatic potential
|
J:136011
|
Dmq4FVB/NJ/?
(involves: FVB/NJ * M16i)
|
increased metastatic potential
|
J:136011
|
Dmtf1tm1Cjs/Dmtf1+
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal metastatic potential
|
J:126002
|
Dmtf1tm1Cjs/Dmtf1+
Krastm3Tyj/Kras+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal metastatic potential
|
J:126002
|
Dmtf1tm1Cjs/Dmtf1tm1Cjs
Krastm2Tyj/Kras+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal metastatic potential
|
J:126002
|
Dock1tm2.1Jfco/Dock1tm2.1Jfco
Tg(MMTV-Erbb2*,-cre)1Mul/0
(involves: C57BL/6 * FVB/NJ)
|
decreased metastatic potential
|
J:196659
|
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6)
|
increased metastatic potential
|
J:33099
|
Ednrbtm1Ywa/Ednrb+
Tg(Mt1-RET)304Ina/0
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6)
|
increased metastatic potential
|
J:155735
|
Epha2Gt(KST085)Byg/Epha2Gt(KST085)Byg
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:112120
|
Epha2tm1Jrui/Epha2tm1Jrui
Krastm4Tyj/Kras+
Trp53tm2.1Tyj/Trp53+
Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * 129S4/SvJae * FVB/N)
|
decreased metastatic potential
|
J:244261
|
Erbb2tm8(Erbb2)Mul/Erbb2+
Ptentm1Hwu/Pten+
Tg(MMTV-cre)7Mul/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N)
|
increased metastatic potential
|
J:133305
|
Erbb3tm1.1(ERBB3)Mul/Erbb3tm1.1(ERBB3)Mul
Tg(MMTV-Erbb2*)NDL2-5Mul/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:189292
|
Errfi1tm1Jwj/Errfi1tm1Jwj
Pgrtm2(cre)Lyd/Pgr+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
increased metastatic potential
|
J:162027
|
Espl1Gt(XL058)Byg/Espl1+
Trp53tm1Tyj/Trp53tm1Tyj
(B6.129-Trp53tm1Tyj Espl1Gt(XL058)Byg)
|
increased metastatic potential
|
J:174926
|
Etv4tm1Hass/Etv4tm1Hass
Tg(MMTVneu)202Mul/Tg(MMTVneu)202Mul
(involves: FVB/N)
|
decreased metastatic potential
|
J:87017
|
Fasldel1Hong/Fasldel1Hong
(either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6))
|
increased metastatic potential
|
J:112563
|
Fbln5tm1Eno/Fbln5tm1Eno
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased metastatic potential
|
J:159246
|
Fgfr4tm1Axul/Fgfr4+
Tg(WapTgfa)215Bri/0
(B6.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri)
|
increased metastatic potential
|
J:156750
|
Fgfr4tm1Axul/Fgfr4tm1Axul
Tg(WapTgfa)215Bri/0
(B6.Cg-Fgfr4tm1Axul Tg(WapTgfa)215Bri)
|
increased metastatic potential
|
J:156750
|
Flot2tm1Mak/Flot2tm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:203238
|
Fostm1Pa/Fostm1Pa
(involves: 129X1/SvJ * C57BL/6J)
|
decreased metastatic potential
|
J:78834
|
Foxn1nu/Foxn1nu
Gpc1tm1.1Alan/Gpc1tm1.1Alan
(involves: CD-1)
|
decreased metastatic potential
|
J:130809
|
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl)
|
decreased metastatic potential
|
J:106671
|
Gadd45atm1Ajf/Gadd45atm1Ajf
Xpctm1Ecf/Xpctm1Ecf
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129X1/SvJ * C57BL/6))
|
increased metastatic potential
|
J:101421
|
Gt(ROSA)26Sortm1(CAG-Mir182)Dgk/Gt(ROSA)26Sortm1(CAG-Mir182)Dgk
Krastm4Tyj/Krastm4Tyj
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased metastatic potential
|
J:217635
|
Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/Gt(ROSA)26Sor+
Ptentm2.1Ppp/Ptentm2.1Ppp
Rb1tm2Brn/Rb1tm2Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * 129S1/Sv * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:307910
|
Gt(ROSA)26Sortm1(GNAQ*)Cvrk/Gt(ROSA)26Sor+
Tg(Mitf-cre)7114Gsb/0
(C3FeJ.Cg-Gt(ROSA)26Sortm1(GNAQ*)Cvkr Tg(Mitf-cre)7114Gsb/Cvrk)
|
increased metastatic potential
|
J:225597
|
Gt(ROSA)26Sortm1(Ntn4)Dyl/Gt(ROSA)26Sor+
Tg(KRT14-cre)1Amc/0
(involves: 129/Sv * C57BL/6 * CBA)
|
increased metastatic potential
|
J:162807
|
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Hmga2tm1.1Mmw/Hmga2+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl * FVB/N)
|
increased metastatic potential
|
J:245611
|
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Krastm4Tyj/Kras+
Tg(Pdx1-cre)6Tuv/0
Trp53tm2Tyj/Trp53+
(involves: 129 * C57BL/6NCrl * FVB/N)
|
increased metastatic potential
|
J:245611
|
Hcsttm1.1Dnax/Hcsttm1.1Dnax
(involves: C57BL/6)
|
decreased metastatic potential
|
J:148086
|
Hic1tm1Sbb/Hic1+
(involves: 129S4/SvJae * C57BL/6)
|
increased metastatic potential
|
J:81448
|
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ)
|
increased metastatic potential
|
J:100773
|
Htatip2tm1Hx/Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased metastatic potential
|
J:87066
|
Hunktm1Lach/Hunk+
Tg(MMTV-Myc)#Led/0
(involves: 129P2/OlaHsd * C57BL/6J * CD-1)
|
decreased metastatic potential
|
J:153075
|
Hunktm1Lach/Hunktm1Lach
Tg(MMTV-Myc)#Led/0
(involves: 129P2/OlaHsd * C57BL/6J * CD-1)
|
decreased metastatic potential
|
J:153075
|
Id1tm1Zhu/Id1+
(involves: 129S1/Sv * 129S4/SvJaeSor)
|
decreased metastatic potential
|
J:86480
|
Id1tm1Zhu/Id1+
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S1/Sv * 129S4/SvJaeSor)
|
decreased metastatic potential
|
J:86480
|
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased metastatic potential
|
J:152785
|
Ifngr1tm1.1Rost/Ifngr1tm1.1Rost
(involves: BALB/cJ * C57BL/6)
|
decreased metastatic potential
|
J:152785
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt/J)
|
increased metastatic potential
|
J:152785
|
Igs2tm1(CAG-Met)Zsu/Igs2+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2 * FVB/N)
|
increased metastatic potential
|
J:268934
|
Il1atm1Yiw/Il1atm1Yiw
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased metastatic potential
|
J:82394
|
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd)
|
decreased metastatic potential
|
J:59893,
J:82394
|
Il5tm1Ktk/Il5tm1Ktk
(B6.129S4-Il5tm1Ktk)
|
increased metastatic potential
|
J:180790
|
Il5ratm1Ktk/Il5ratm1Ktk
(involves: 129P2/OlaHsd)
|
increased metastatic potential
|
J:180790
|
Immp2lTg(HLA-A/H2-D)2Enge/0
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6 * CBA/Ca)
|
increased metastatic potential
|
J:130879
|
Inpp5jtm1.1Cmit/Inpp5jtm1.1Cmit
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6)
|
decreased metastatic potential
|
J:224914
|
Itgaltm1Wpfl/Itgaltm1Wpfl
(involves: 129)
|
increased metastatic potential
|
J:37160
|
Itgb1tm1Ref/Itgb1tm1Ref
Tg(Ins2-cre)1Heed/?
Tg(RIP1-Tag)2Dh/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * CBA * DBA/2J)
|
decreased metastatic potential
|
J:122649
|
Jam3tm1.1Chav/Jam3tm1.1Chav
Tg(Tal1-cre/ERT)1Jrg/?
(involves: 129 * C57BL/6)
|
decreased metastatic potential
|
J:173391
|
Jam3tm1.1Chav/Jam3tm1.2Chav
Tg(Cdh5-cre)7Mlia/?
(involves: 129 * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:173391
|
Jam3tm1.2Chav/Jam3tm1.2Chav
(B6.129-Jam3tm1.2Chav)
|
decreased metastatic potential
|
J:173391
|
Kars1Gt(AJ0130)Wtsi/Kars1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased metastatic potential
|
J:264950
|
Krastm1Bbd/Kras+
Trp53tm1Brd/Trp53+
Tg(Cela1-tTA)#Eps/?
Tg(tetO-cre)3Jig/?
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * FVB/N)
|
increased metastatic potential
|
J:119988
|
Krastm2Tyj/Kras+
Trp53tm1Glo/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd)
|
increased metastatic potential
|
J:129627
|
Krastm4Tyj/Kras+
Ptentm1Hwu/Pten+
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:184935
|
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * C57BL/6J)
|
increased metastatic potential
|
J:96296
|
Krastm4Tyj/Kras+
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:184935
|
Krastm4Tyj/Kras+
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(TPO-cre)1Shk/0
(129.Cg-Krastm4Tyj Tg(Tpo-cre)1Shk Ptentm2.1Ppp)
|
increased metastatic potential
|
J:147732
|
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(B6.129(Cg)-Krastm4Tyj Ptf1atm1.1(cre)Cvw)
|
increased metastatic potential
|
J:138959
|
Krastm4Tyj/Kras+
Ptf1atm1.1(cre)Cvw/Ptf1a+
Tg(MUC1)79.24Gend/0
(B6.Cg-Krastm4Tyj Ptf1atm1.1(cre)Cvw Tg(MUC1)79.24Gend)
|
decreased metastatic potential
|
J:138959
|
Krastm4Tyj/Kras+
Rab11fip1tm1.1Jicn/Rab11fip1tm1.1Jicn
Tg(Pdx1-cre)6Tuv/0
Trp53tm2.1Tyj/Trp53+
(involves: 129S4/SvJae * FVB/N)
|
decreased metastatic potential
|
J:244261
|
Krastm4Tyj/Kras+
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Tg(Krt1-15-cre/PGR*)22Cot/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * SJL/J)
|
increased metastatic potential
|
J:203922
|
Krastm4Tyj/Kras+
Stk11tm1.1Rdp/Stk11tm1.1Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:124682
|
Krastm4Tyj/Kras+
Stk11tm1.1Rdp/Stk11tm1.2Rdp
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:124682
|
Krastm4Tyj/Kras+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:108298
|
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2+
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:116129
|
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
(B6.129-Krastm4Tyj Tgfbr2tm1.2Hlm)
|
increased metastatic potential
|
J:177379
|
Krastm4Tyj/Kras+
Tgfbr2tm1.2Hlm/Tgfbr2tm1.2Hlm
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:116129
|
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
increased metastatic potential
|
J:184949
|
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53+
Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:108298
|
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased metastatic potential
|
J:103407
|
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased metastatic potential
|
J:125101
|
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:124682
|
Krastm4Tyj/Kras+
Trp53tm1Brn/Trp53tm1Brn
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA)
|
increased metastatic potential
|
J:184949
|
Krastm4Tyj/Kras+
Trp53tm2Tyj/Trp53+
Zdhhc20em1Jdo/Zdhhc20em1Jdo
Tg(Pdx1-cre)6Tuv/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:348743
|
Krastm4Tyj/Kras+
Trp53tm3Glo/Trp53+
Tg(KRT5-cre/PGR)1Der/?
(involves: 129/Sv * C57BL/6 * FVB * ICR)
|
increased metastatic potential
|
J:124222
|
Krastm4Tyj/Krastm4Tyj
Mir182tm1.1Dgk/Mir182+
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased metastatic potential
|
J:217635
|
Krastm4Tyj/Krastm4Tyj
Mir182tm1.1Dgk/Mir182tm1.1Dgk
Trp53tm1Brn/Trp53tm1Brn
(involves: 129/Sv * 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased metastatic potential
|
J:217635
|
Krt14tm1(cre)Wbm/Krt14+
Pard3tm1Shoh/Pard3tm1Shoh
(either: FVB.129-Pard3tm1Shoh Krt14tm1(cre)Wbm or (involves: 129P2/OlaHsd * 129S4/SvJae))
|
increased metastatic potential
|
J:192905
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
increased metastatic potential
|
J:117826
|
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J)
|
increased metastatic potential
|
J:117826
|
Lystbg-2J/Lystbg-2J
(C3.Cg-Lystbg-2J/J)
|
abnormal metastatic potential
|
J:33522
|
| decreased metastatic potential
|
J:33522
|
Map3k1tm1Glj/Map3k1tm1Glj
Tg(MMTV-PyVT)634Mul/0
(involves: 129S/SvEv * FVB/N)
|
decreased metastatic potential
|
J:112298
|
Mcm3tm1.1Geno/Mcm3+
(involves: 129S2/SvPas * C57BL/6)
|
increased metastatic potential
|
J:227638
|
Mcm3tm1.2Geno/Mcm3+
(involves: 129S2/SvPas * C57BL/6)
|
increased metastatic potential
|
J:227638
|
Men1tm1.1Ctre/Men1+
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
increased metastatic potential
|
J:133299
|
Mfge8tm1Mcu/Mfge8tm1Mcu
Tg(RIP1-Tag)2Dh/?
(involves: 129X1/SvJ * C57BL/6J * C57BL/6NCr * DBA/2J)
|
decreased metastatic potential
|
J:123138
|
Mgat5tm1Jwd/Mgat5tm1Jwd
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased metastatic potential
|
J:60960
|
Mir31em1Nju/Mir31em1Nju
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6J * FVB/N)
|
decreased metastatic potential
|
J:271420
|
Mmp9tm1Itoh/Mmp9tm1Itoh
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased metastatic potential
|
J:55823
|
Mmp9tm1Tvu/Mmp9tm1Tvu
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:140033
|
Mmp9tm1Tvu/Mmp9tm1Tvu
Tg(MMTV-PyVT)634Mul/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:140033
|
Mmp11tm1Mrio/Mmp11tm1Mrio
Tg(MMTV-vHaras)SH1Led/Tg(MMTV-vHaras)SH1Led
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6J * CD-1 * FVB)
|
increased metastatic potential
|
J:86074
|
Msmbtm1Xuan/Msmbtm1Xuan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
increased metastatic potential
|
J:96884
|
Mtbptm1Glo/Mtbp+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J)
|
increased metastatic potential
|
J:135509
|
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(MMTV-PyVT)634Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTV-PyVT)634Mul)
|
decreased metastatic potential
|
J:214244
|
MtdhGt(XB780)Byg/MtdhGt(XB780)Byg
Tg(MMTVneu)202Mul/0
(FVB.Cg-MtdhGt(XB780)Byg Tg(MMTVneu)202Mul)
|
decreased metastatic potential
|
J:214244
|
Nbeal2tm1a(EUCOMM)Wtsi/Nbeal2tm1a(EUCOMM)Wtsi
(C57BL/6N-Nbeal2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased metastatic potential
|
J:220801
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S6/SvEvTac * C57BL/6J * CD-1)
|
decreased metastatic potential
|
J:88789
|
Nf1tm1Tyj/Nf1+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6)
|
increased metastatic potential
|
J:228258
|
Nmitm1.1Geno/Nmitm1.1Geno
Tg(KRT14-cre)1Amc/0
(B6.Cg-Nmitm1.1Geno Tg(KRT14-cre)1Amc)
|
increased metastatic potential
|
J:261035
|
Nmitm1.1Geno/Nmitm1.1Geno
Tg(KRT14-cre)1Amc/0
Tg(MMTVneu)202Mul/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:261035
|
Npr1tm1.1Kkan/Npr1tm1.1Kkan
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)
|
increased metastatic potential
|
J:220676
|
Plautm1Mlg/Plautm1Mlg
(B6.Cg-Plautm1Mlg)
|
decreased metastatic potential
|
J:65383
|
Pld1tm1.1Mafr/Pld1tm1.1Mafr
(B6.Cg-Pld1tm1.1Mafr)
|
decreased metastatic potential
|
J:193451
|
Pldmq1FVB/NJ/?
(involves: FVB/NJ * M16i)
|
increased metastatic potential
|
J:136011
|
Pldmq2FVB/NJ/?
(involves: FVB/NJ * M16i)
|
increased metastatic potential
|
J:136011
|
Pldmq2M16i/?
(involves: FVB/NJ * M16i)
|
increased metastatic potential
|
J:136011
|
Pldmq3FVB/NJ/?
(involves: FVB/NJ * M16i)
|
increased metastatic potential
|
J:136011
|
Plgtm1Jld/Plgtm1Jld
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * Black Swiss * FVB/N)
|
decreased metastatic potential
|
J:48285
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk
Ptentm1.1Mwst/Ptentm1.1Mwst
Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)
|
increased metastatic potential
|
J:225245
|
Ptch1tm1Yy/Ptch1+
Trp53tm1Brd/Trp53+
Tg(BGLAP-cre)1Clem/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/NJ)
|
increased metastatic potential
|
J:214349
|
Ptentm1.1Hwu/Pten+
(involves: 129S4/SvJae * BALB/c)
|
abnormal metastatic potential
|
J:110567
|
Ptentm1.1Mro/Pten+
(Not Specified)
|
increased metastatic potential
|
J:236514
|
Ptentm1.1Mro/Pten+
Sdhbtm1.2Ics/Sdhb+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
increased metastatic potential
|
J:236514
|
Ptentm1Hwu/Pten+
Tg(ARR2/Pbsn-FGF8)3Prb/0
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:106650
|
Ptentm1Hwu/Ptentm1Hwu
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
increased metastatic potential
|
J:142150
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Fabp1-cre)1Jig/0
(involves: 129S4/SvJae * FVB/N)
|
increased metastatic potential
|
J:106662
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Pbsn-cre)4Prb/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:268934
|
Ptentm1Hwu/Ptentm1Hwu
Trp53tm2Tyj/Trp53+
Amhr2tm3(cre)Bhr/Amhr2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S7/SvEvBrd)
|
increased metastatic potential
|
J:222579
|
Ptentm1Rdp/Ptentm1Rdp
Smad4tm1Rdp/Smad4tm1Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129 * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:186105
|
Ptentm1Rdp/Ptentm1Rdp
Terttm3Rdp/Terttm3Rdp
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:186105
|
Ptentm1Rps/Pten+
Tg(Wnt1)1Hev/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL)
|
increased metastatic potential
|
J:67497
|
Ptentm2.1Ppp/Ptentm2.1Ppp
Trp53tm1Brn/Trp53tm1Brn
Tg(TPO-cre)1Shk/0
(129.Cg-Tg(TPO-cre)1Shk Trp53tm1Brn Ptentm2.1Ppp)
|
increased metastatic potential
|
J:211100
|
Ptentm2Mak/Ptentm2Mak
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * DBA)
|
increased metastatic potential
|
J:90905
|
Ptentm2Mak/Ptentm2Mak
Tg(KLK3-cre)13Saa/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased metastatic potential
|
J:214242
|
Ptk2tm3.1Guan/Ptk2tm3.1Guan
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
decreased metastatic potential
|
J:195658
|
Puf60tm1.1Kmtsu/Puf60+
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj)
|
increased metastatic potential
|
J:233347
|
Rasal2Gt(463C12)Cmhd/Rasal2+
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl)
|
increased metastatic potential
|
J:202603
|
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Tg(MMTVneu)202Mul/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl * FVB/N)
|
increased metastatic potential
|
J:202603
|
Rasal2Gt(463C12)Cmhd/Rasal2Gt(463C12)Cmhd
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S * 129X1/SvJ * C57BL/6 * C57BL/6NCrl)
|
increased metastatic potential
|
J:202603
|
Rb1tm1Brd/Rb1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased metastatic potential
|
J:17434
|
Rb1tm1Tyj/Rb1+
(involves: 129S2/SvPas * C57BL/6J)
|
increased metastatic potential
|
J:133299
|
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd)
|
increased metastatic potential
|
J:84345
|
Rb1tm2Brn/Rb1tm2Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Ren-cre)#Kwg/0
(involves: 129 * 129P2/OlaHsd)
|
increased metastatic potential
|
J:216559
|
Rb1tm3Tyj/Rb1+
Trp53tm1Brn/Trp53+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N)
|
increased metastatic potential
|
J:136693
|
Rb1tm3Tyj/Rb1+
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N)
|
increased metastatic potential
|
J:136693
|
Rb1tm3Tyj/Rb1tm3Tyj
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
increased metastatic potential
|
J:199542
|
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53+
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N)
|
increased metastatic potential
|
J:136693
|
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J * CD-1 * FVB/N)
|
increased metastatic potential
|
J:318035
|
Rb1tm3Tyj/Rb1tm3Tyj
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CD-1)
|
increased metastatic potential
|
J:199542
|
Rhoctm1Mak/Rhoctm1Mak
Tg(MMTV-PyVT)634Mul/0
(involves: 129P2/OlaHsd * FVB/N)
|
decreased metastatic potential
|
J:100482
|
Rhojtm1.2Auem/Rhojtm1.2Auem
(B6.Cg-Rhojtm1.2Auem)
|
decreased metastatic potential
|
J:208154
|
Rhojtm1.2Auem/Rhojtm1.2Auem
Tg(MMTV-PyVT)634Mul/0
(involves: C57BL/6 * CBA/JNCrlj * FVB/N)
|
decreased metastatic potential
|
J:208154
|
Rnf19btm1Jkorn/Rnf19btm1Jkorn
(B6.129S-Rnf19btm1Jkorn)
|
increased metastatic potential
|
J:157393
|
Rpl27aSfa/Rpl27a+
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J)
|
increased metastatic potential
|
J:174216
|
Rr149356tm1Che/Rr149356tm1Che
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
decreased metastatic potential
|
J:106246
|
Runx1tm1(RUNX1)Gcg/Runx1tm1(RUNX1)Gcg
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased metastatic potential
|
J:106800
|
Selltm2Hyn/Selltm2Hyn
(involves: 129S2/SvPas * C57BL/6)
|
decreased metastatic potential
|
J:106671
|
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N)
|
increased metastatic potential
|
J:297725
|
Setd4tm1c(KOMP)Wtsi/Setd4tm1c(KOMP)Wtsi
Trp53tm1Brn/Trp53tm1Brn
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * C57BL/6N)
|
decreased metastatic potential
|
J:297725
|
Shc1tm5Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased metastatic potential
|
J:133325
|
Shc1tm5Paw/Shc1tm5Paw
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased metastatic potential
|
J:133325
|
Shc1tm6Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased metastatic potential
|
J:133325
|
Shc1tm6Paw/Shc1tm6Paw
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased metastatic potential
|
J:133325
|
Shc1tm7Paw/Shc1+
Tg(MMTV-PyVT)634Mul/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
decreased metastatic potential
|
J:133325
|
Slc6a14tm1Gana/Slc6a14tm1Gana
Tg(MMTV-PyVT)634Mul/0
(Not Specified)
|
decreased metastatic potential
|
J:226105
|
Smad3tm1Par/Smad3tm1Par
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased metastatic potential
|
J:49839
|
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Trp53tm1Brn/Trp53tm1Brn
Tg(MMTV-cre)7Mul/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * FVB/N)
|
increased metastatic potential
|
J:212549
|
Stab2tm1Ami/Stab2tm1Ami
(B6.Cg-Stab2tm1Ami)
|
decreased metastatic potential
|
J:182239
|
Stat3tm4Vpo/Stat3tm4Vpo
Tg(MMTV-Erbb2)1Pv/0
(involves: 129P2/OlaHsd * BALB/cAn * C57BL/6 * CD-1 * DBA)
|
increased metastatic potential
|
J:157976
|
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru)
|
decreased metastatic potential
|
J:65894
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp
Tg(Sprr2f-cre)1Dcas/0
(involves: 129S6/SvEvTac * FVB/N)
|
increased metastatic potential
|
J:158190
|
Tbx21tm1Glm/Tbx21tm1Glm
Tg(TRAMP)8247Ng/0
(involves: 129S6/SvEvTac * C57BL/6)
|
increased metastatic potential
|
J:88093
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
Tg(Pklr-Myc)73Ak/0
(B6.Cg-Tcra-Jtm1Tgi Tg(Pklr-Myc)73Ak)
|
increased metastatic potential
|
J:184496
|
Tg(Amy1TAg)501Knw/?
(C57BL/6-Tg(Amy1TAg)501Knw)
|
increased metastatic potential
|
J:90730
|
Tg(Bglap2-TAg)1Rkho/0
(FVB/N-Tg(Bglap2-TAg)1Rkho)
|
increased metastatic potential
|
J:165282
|
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
Tg(Dbh-icre)1Gsc/0
(involves: C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:186696
|
Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
Thtm1(cre)Te/Th+
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:186696
|
Tg(CAG-Bgeo,-tTA,-EGFP)2A11Kuw/0
Tg(Pdx1-cre)6Tuv/0
Tg(tetO-MYC)36Bop/0
(involves: 129P2/OlaHsd * FVB/N)
|
increased metastatic potential
|
J:197052
|
Tg(CAG-lacZ,-SV40)#Bcv/0
(involves: FVB/N)
|
increased metastatic potential
|
J:158388
|
Tg(Cela1-luc,Cela1-TAg)#Nzh/0
(involves: FVB/N)
|
increased metastatic potential
|
J:207960
|
Tg(CMV-tTA)3Bjd/0
Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL)
|
increased metastatic potential
|
J:94953
|
Tg(Dct-Birc5)21Gros/0
Tg(Mt1-Hgf)19Lmb/0
(involves: C57BL/6 * CBA * FVB/N)
|
increased metastatic potential
|
J:122181
|
Tg(Ela1-Myc)158Bri/0
(involves: C57BL/6 * SJL)
|
increased metastatic potential
|
J:76992
|
Tg(Ela1-Myc)159Bri/0
(involves: C57BL/6 * SJL)
|
increased metastatic potential
|
J:76992
|
Tg(Ela1-Myc)160Bri/0
(involves: C57BL/6 * SJL)
|
increased metastatic potential
|
J:76992
|
Tg(Ela1-TAg*)79Mjt/0
(involves: C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:78026
|
Tg(Gcg-TAg)25Ddr/?
(involves: CD-1)
|
increased metastatic potential
|
J:91490,
J:101537
|
Tg(IghMyc)22Bri/?
(involves: C57BL * C57BL/6 * SJL)
|
increased metastatic potential
|
J:121564
|
Tg(KRT14-Snai1)1Efu/0
(involves: CD-1)
|
increased metastatic potential
|
J:229072
|
Tg(KRT19-TAg)7Eps/0
(involves: FVB/N)
|
increased metastatic potential
|
J:64395
|
Tg(MMTV-ERBB2)5Erick/?
(FVB/N-Tg(MMTV-ERBB2)5Erick)
|
increased metastatic potential
|
J:90202
|
Tg(MMTV-KRAS*G12V)3025Mrl/0
(involves: C57BL/6 * FVB * SJL)
|
increased metastatic potential
|
J:77272
|
Tg(MMTV-LPAR1)#Gbm/Tg(MMTV-LPAR1)#Gbm
(FVB/N-Tg(MMTV-LPAR1)#Gbm)
|
increased metastatic potential
|
J:149661
|
Tg(MMTV-LPAR2)#Gbm/Tg(MMTV-LPAR2)#Gbm
(FVB/N-Tg(MMTV-LPAR2)#Gbm)
|
increased metastatic potential
|
J:149661
|
Tg(MMTV-LPAR3)#Gbm/Tg(MMTV-LPAR3)#Gbm
(FVB/N-Tg(MMTV-LPAR3)#Gbm)
|
increased metastatic potential
|
J:149661
|
Tg(MMTV-Myc)WT13Jrn/0
(involves: FVB/N)
|
increased metastatic potential
|
J:153233
|
Tg(MMTV-Myc)WT21Jrn/0
(involves: FVB/N)
|
increased metastatic potential
|
J:153233
|
Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr)
|
increased metastatic potential
|
J:93548
|
Tg(MMTV-Notch4)3Rnc/0
(involves: FVB/N)
|
increased metastatic potential
|
J:11644
|
Tg(MMTV-PyVT)634Mul/0
(FVB/N-Tg(MMTV-PyVT)634Mul/Nci)
|
increased metastatic potential
|
J:46460,
J:48285
|
Tg(MMTV-PyVT)634Mul/0
(multiple strains)
|
decreased metastatic potential
|
J:48854
|
| increased metastatic potential
|
J:48854
|
Tg(MMTV-PyVT)#Mul/0
(B6.FVB-Tg(MMTV-PyVT)#Mul)
|
increased metastatic potential
|
J:147923
|
Tg(MMTV-rtTA)1Lach/0
Tg(TetO-Erbb2)1Lach/0
(involves: FVB)
|
increased metastatic potential
|
J:81083
|
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-ERBB2)#Jjz/0
(involves: FVB/N)
|
increased metastatic potential
|
J:231766
|
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-PyVT,-cre)1Mul/0
(FVB/N-Tg(MMTV-rtTA)1Lach Tg(tetO-PyVT,-cre)#Mul)
|
increased metastatic potential
|
J:231983
|
Tg(MMTV-vHaras)SH1Led/Tg(MMTV-vHaras)SH1Led
(involves: 129X1/SvJ * C57BL/6J * CD-1 * FVB)
|
increased metastatic potential
|
J:86074
|
Tg(MMTVneu)202Mul/0
(FVB/N-Tg(MMTVneu)202Mul)
|
increased metastatic potential
|
J:56332
|
Tg(Msmb-TAg)183-2Xuan/0
(involves: C57BL/6 * CBA)
|
increased metastatic potential
|
J:80313
|
Tg(Mt1-Hgf)19Lmb/0
(involves: FVB/N)
|
increased metastatic potential
|
J:50947
|
Tg(Mt1-RET)304Ina/0
(involves: BALB/c * C57BL/6)
|
increased metastatic potential
|
J:155735
|
Tg(OMP-SV40T)13Bse/0
(involves: C57BL/6 * SJL)
|
increased metastatic potential
|
J:54269
|
Tg(Pbsn-Ar*E231G)7353Ng/0
(involves: FVB/N)
|
increased metastatic potential
|
J:96117
|
Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp/0
(FVB-Tg(Pbsn-Fgfr1/Fkbp1a)#aDmsp)
|
increased metastatic potential
|
J:130340
|
Tg(Pbsn-Hpn,-GFP)DVv/0
Tg(Pbsn-Tag)12T7fRjm/0
(involves: C57BL/6J * CBA * CD-1)
|
increased metastatic potential
|
J:92562
|
Tg(Pbsn-IGF1*)5305Ng/0
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * FVB/N)
|
abnormal metastatic potential
|
J:144539
|
Tg(Pbsn-Tag)12T10Rjm/0
(involves: CD-1)
|
increased metastatic potential
|
J:68483
|
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-EGFR*T790M*L858R)19Kkw/0
(involves: 129 * C57BL/6 * FVB/N)
|
increased metastatic potential
|
J:122849
|
Tg(Scgb1a1-rtTA)1Jaw/0
Tg(tetO-MYC)36Bop/0
(involves: 129 * C57BL/6)
|
increased metastatic potential
|
J:169920
|
Tg(SERPINC1-SV40)A1Pbr/0
(involves: C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:101541
|
Tg(SFTPC-CCNE1)1Edm/?
(involves: FVB/N)
|
increased metastatic potential
|
J:122698
|
Tg(SFTPC-CCNE1*T62A*T380A)3Edm/?
(involves: FVB/N)
|
increased metastatic potential
|
J:122698
|
Tg(SFTPC-CCNE1*T62A*T380A)4Edm/?
(involves: FVB/N)
|
increased metastatic potential
|
J:122698
|
Tg(SFTPC-env)1Yhch/0
(FVB/N-Tg(SFTPC-env)1Yhch)
|
increased metastatic potential
|
J:247986
|
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-MYC)36Bop/0
(Not Specified)
|
increased metastatic potential
|
J:169920
|
Tg(Slc1a2-tTA)#Waw/0
Tg(tetO-MYCN,-luc)#Waw/0
(involves: FVB/NJ)
|
increased metastatic potential
|
J:160518
|
Tg(Slc1a2-tTA)#Waw/0
Tg(tetO-MYCN,-luc)#Waw/Tg(tetO-MYCN,-luc)#Waw
(involves: FVB/NJ)
|
increased metastatic potential
|
J:160518
|
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Tg(tetO-RNAi:Trp53)ASlowe/0
(involves: C57BL/6 * CD-1)
|
increased metastatic potential
|
J:199542
|
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
Trp53tm1Brn/Trp53tm1Brn
(involves: 129 * 129P2/OlaHsd * C57BL/6J * CD-1 * FVB/N)
|
increased metastatic potential
|
J:136693
|
Tg(Tal1-cre/ERT)1Jrg/0
Tsc1tm1Djk/Tsc1tm1Djk
(involves: 129S4/SvJae * C57BL/6)
|
increased metastatic potential
|
J:231316
|
Tg(Tek-Npr1)#Kkan/0
(involves: C57BL/6)
|
decreased metastatic potential
|
J:220676
|
Tg(TG-NRAS*Q61K)#Msnt/0
(Not Specified)
|
increased metastatic potential
|
J:210016
|
Tg(TG-RET/NCOA4)3209Rstn/0
(involves: C57BL/6)
|
increased metastatic potential
|
J:51366
|
Tg(TG-SV40)#Cled/0
(involves: C57BL/6J * DBA/2J)
|
increased metastatic potential
|
J:209788
|
Tg(TRAMP)8247Ng/0
Tmprss2tm1Psn/Tmprss2tm1Psn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased metastatic potential
|
J:217920
|
Tg(TRAMP)8247Ng/0
Usp11tm1Tac/Y
(involves: 129 * C57BL/6)
|
increased metastatic potential
|
J:270214
|
Tg(UPII-SV40T)29Xrw/0
(involves: FVB/N)
|
increased metastatic potential
|
J:56305
|
Tg(Upk2-TAg)1Rkl/0
(involves: C57BL/6)
|
abnormal metastatic potential
|
J:173505
|
Tg(Wap-Hgf)402Mig/0
(involves: FVB/N)
|
increased metastatic potential
|
J:86776
|
X/Tg(Wap-HRAS)69Lln
(involves: C57BL/6 * SJL)
|
abnormal metastatic potential
|
J:46458
|
Tgfb1i1tm1.2Cet/Tgfb1i1tm1.2Cet
Tg(MMTV-PyVT)634Mul/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:241234
|
Tle5tm1.1Mmt/Tle5tm1.1Mmt
Apctm1Mmt/Apc+
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S2/SvPas * C57BL/6 * DBA * SJL)
|
increased metastatic potential
|
J:168065
|
Tmem219tm1(KOMP)Vlcg/Tmem219tm1(KOMP)Vlcg
(B6J.B6N-Tmem219tm1(KOMP)Vlcg)
|
decreased metastatic potential
|
J:236976
|
Tnfrsf10btm1.1Cjk/Tnfrsf10btm1.1Cjk
(involves: 129P2/OlaHsd * BALB/c * NIH/OlaHsd)
|
increased metastatic potential
|
J:130806
|
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased metastatic potential
|
J:133892
|
Tpx2Gt(D028B03)Wrst/Tpx2+
(involves: 129S2/SvPas * C57BL/6J)
|
increased metastatic potential
|
J:184948
|
Trim16tm1Gmma/Trim16+
Tg(KRT14-cre)1Cgn/0
(involves: C57BL/6 * DBA/2)
|
increased metastatic potential
|
J:290272
|
Trp53tm1Brn/Trp53tm1Brn
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
increased metastatic potential
|
J:199542
|
Trp53tm1Glo/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased metastatic potential
|
J:61683
|
Trp53tm1Tyj/Trp53+
Trp63tm1Fmc/Trp63+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased metastatic potential
|
J:98958
|
Trp53tm1Tyj/Trp53+
Trp73tm1Fmc/Trp73+
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
increased metastatic potential
|
J:98958
|
Trp53tm2.1Tyj/Trp53+
(involves: 129S4/SvJae)
|
increased metastatic potential
|
J:95316
|
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo)
|
increased metastatic potential
|
J:95318
|
Trp53tm3.1Tyj/Trp53+
(involves: 129S4/SvJae)
|
increased metastatic potential
|
J:95316
|
Trp53tm6Xu/Trp53tm6Xu
Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
increased metastatic potential
|
J:157041
|
Trp63tm1Fmc/Trp63+
Trp73tm1Fmc/Trp73+
(involves: 129S4/SvJae * C57BL/6)
|
increased metastatic potential
|
J:98958
|
Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
Pgrtm2(cre)Lyd/Pgr+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased metastatic potential
|
J:221228
|
Ube2otm1.1(KOMP)Mbp/Ube2otm1.1(KOMP)Mbp
Tg(TRAMP)8247Ng/0
(involves: C57BL/6 * C57BL/6N * FVB/N)
|
decreased metastatic potential
|
J:239679
|
Vegfatm2Gne/Vegfatm2Gne
Tg(Csf1r-cre/Esr1*)1Jwp/0
(involves: 129 * C57BL/6 * FVB/N)
|
decreased metastatic potential
|
J:186831
|
Vegfdtm1Hrl/Y
(B6.129S-Vegfdtm1Hrl)
|
decreased metastatic potential
|
J:153734
|
Xpatm1Tnka/Xpatm1Tnka
Tg(KRT14-Kitl)1Takk/?
(involves: C57BL/6 * CBA * SJL)
|
increased metastatic potential
|
J:100608
|
Analysis Tools